Ketim Technologies CEO Presents on Precision Medicine for Mental Health at Translational Research Institute Seminar

Brisbane, Australia – March 21, 2025 – Ketim Technologies, a pioneer in biomarker-based diagnostics for perinatal mental health, is proud to share that Founder and CEO, Dr. Clarissa Yates, Ph.D., presented at the Power Up Your Multi-Omic Discoveries | Next Gen Olink® Proteomics seminar, hosted by the Australian Genome Research Facility (AGRF Ltd) at the Translational Research Institute, Brisbane.

The seminar brought together leaders in genomics, proteomics, and precision medicine to explore how multi-omic integration is transforming disease research and enabling the discovery of novel biomarkers. Dr. Yates presented Ketim Technologies’ work in advancing early detection of postpartum depression through the integration of proteomic data, AI analytics, and clinical insights, demonstrating how this approach is shaping a new era in mental health diagnostics.

Also presenting at the event were Dr. Benjamin Cooper, Technical Officer – Olink, AGRF, and Dr. Saurabh Shrivastava, Senior Account Manager, AGRF. The seminar offered both in-person and live-streamed access, drawing an engaged audience of researchers, clinicians, and innovators.

“Multi-omic integration is unlocking new possibilities for personalised mental health care,” said Dr. Yates. “Our work at Ketim Technologies is proof that advanced molecular science can be directly translated into impactful, real-world solutions for mothers and families.”

For media inquiries, please contact:
Dr. Clarissa Yates
CEO, Ketim Technologies
clarissa.yates@ketim.com.au